MVA-BN WNV (Bavarian Nordic)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameMVA-BN WNV (Bavarian Nordic)
Drug Alias NameMVA-BN West Nile virus (Bavarian Nordic)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsWest Nile Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBavarian Nordic A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBavarian Nordic A/S
Active IndicationsN/A
Inactive IndicationsWest Nile Fever

Other Information

ATC CodeN/A
Related LinksN/A